🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cognitive impairment is a key disabling feature of SZ. The impairment affec...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01879709
Treatments Being Tested
The purpose of this study is to evaluate the mucolytic activity of Tacholiq...
Status
Completed
Location
Medaimun GmbH
Start Date
2014-08
Trial ID
NCT02515799
Treatments Being Tested
People with asthma suffer from breathlessness because the small tubes (bron...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-20
Trial ID
NCT01400906
Treatments Being Tested
The overall objective of this study was to assess the efficacy and safety o...
Status
Completed
Location
Pearl Investigative Site
Start Date
2015-01-28
Trial ID
NCT03256552
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
Safety, tolerability and pharmacokinetic study of BIIX 1 XX in healthy male...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02198287
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
The primary objective of this study is to demonstrate that there are no cli...
Status
Completed
Location
Altana/Nycomed
Start Date
2004-12
Trial ID
NCT00659048
Treatments Being Tested
This is a 6 week study to assess the effect of BI 671800 in patients with a...
Status
Completed
Location
1268.16.01004 Boehringer Ingelheim Investigational Site
Start Date
2010-04-20
Trial ID
NCT01103349
Treatments Being Tested